Medtronic - 43 Year Stock Price History | MDT
Historical daily share price chart and data for Medtronic since 1981 adjusted for splits and dividends. The latest closing stock price for Medtronic as of April 24, 2024 is 80.38.
- The all-time high Medtronic stock closing price was 124.38 on September 08, 2021.
- The Medtronic 52-week high stock price is 92.02, which is 14.5% above the current share price.
- The Medtronic 52-week low stock price is 68.84, which is 14.4% below the current share price.
- The average Medtronic stock price for the last 52 weeks is 82.70.
| Medtronic Historical Annual Stock Price Data | ||||||
|---|---|---|---|---|---|---|
| Year | Average Stock Price | Year Open | Year High | Year Low | Year Close | Annual % Change |
| 2024 | 84.1001 | 82.1603 | 87.3673 | 79.0800 | 80.3800 | -1.62% |
| 2023 | 79.5823 | 75.0606 | 88.4126 | 68.2862 | 81.7041 | 9.61% |
| 2022 | 88.7169 | 98.7078 | 105.8340 | 72.3760 | 74.5427 | -22.55% |
| 2021 | 112.0769 | 105.6961 | 124.3780 | 92.0252 | 96.2424 | -9.81% |
| 2020 | 92.7699 | 101.9800 | 107.9798 | 64.9125 | 106.7165 | 5.67% |
| 2019 | 86.9695 | 76.6616 | 101.4754 | 71.8921 | 100.9919 | 27.33% |
| 2018 | 75.8229 | 70.5119 | 86.2689 | 65.6573 | 79.3124 | 14.51% |
| 2017 | 69.2571 | 59.5799 | 75.8012 | 59.5799 | 69.2597 | 15.23% |
| 2016 | 67.0882 | 62.6114 | 74.2135 | 60.0085 | 60.1031 | -5.44% |
| 2015 | 61.4547 | 58.2577 | 64.6077 | 53.0544 | 63.5617 | 8.62% |
| 2014 | 50.5707 | 45.5504 | 60.9938 | 42.6537 | 58.5171 | 28.13% |
| 2013 | 40.4441 | 32.6350 | 46.5963 | 32.6350 | 45.6697 | 42.87% |
| 2012 | 30.5714 | 29.2223 | 34.5959 | 27.4482 | 31.9648 | 10.64% |
| 2011 | 27.6595 | 27.5394 | 32.1803 | 22.7971 | 28.8899 | 5.81% |
| 2010 | 28.3536 | 31.6202 | 33.3043 | 22.8226 | 27.3038 | -13.81% |
| 2009 | 25.0484 | 23.0670 | 32.3404 | 17.2455 | 31.6778 | 42.53% |
| 2008 | 32.7991 | 34.4571 | 39.6081 | 20.1563 | 22.2253 | -36.33% |
| 2007 | 35.8585 | 36.2552 | 40.0869 | 31.4193 | 34.9050 | -5.22% |
| 2006 | 34.7035 | 39.4909 | 40.7116 | 29.1629 | 36.8264 | -6.29% |
| 2005 | 36.6706 | 33.5078 | 39.9278 | 33.1036 | 39.2997 | 16.72% |
| 2004 | 33.4655 | 32.6643 | 36.1177 | 31.3491 | 33.6705 | 2.68% |
| 2003 | 31.7888 | 31.3068 | 35.4112 | 28.9058 | 32.7925 | 7.23% |
| 2002 | 29.6791 | 33.3437 | 33.3437 | 22.5645 | 30.5825 | -10.35% |
| 2001 | 30.8349 | 39.4519 | 39.4519 | 25.9380 | 34.1114 | -14.80% |
| 2000 | 33.9599 | 22.6227 | 40.4465 | 22.6227 | 40.0354 | 66.33% |
| 1999 | 24.0199 | 24.0327 | 29.0161 | 20.6397 | 24.0693 | -1.49% |
| 1998 | 19.1096 | 16.3951 | 25.2268 | 14.9608 | 24.4340 | 42.11% |
| 1997 | 13.3600 | 10.9756 | 17.1943 | 9.5225 | 17.1943 | 55.23% |
| 1996 | 9.3610 | 8.4235 | 11.2200 | 7.6433 | 11.0766 | 22.37% |
| 1995 | 6.7692 | 4.3246 | 9.6999 | 4.2939 | 9.0520 | 101.79% |
| 1994 | 3.5755 | 3.2977 | 4.4858 | 2.8244 | 4.4858 | 36.94% |
| 1993 | 2.8553 | 3.7528 | 3.7528 | 2.1134 | 3.2758 | -13.04% |
| 1992 | 3.3162 | 3.6560 | 4.0933 | 2.5279 | 3.7670 | 1.94% |
| 1991 | 2.4510 | 1.6405 | 3.6953 | 1.5492 | 3.6953 | 119.72% |
| 1990 | 1.4613 | 1.2632 | 1.7842 | 1.1512 | 1.6818 | 32.90% |
| 1989 | 1.0067 | 0.7408 | 1.3475 | 0.7408 | 1.2655 | 71.38% |
| 1988 | 0.7778 | 0.8990 | 0.9367 | 0.6586 | 0.7384 | -15.77% |
| 1987 | 0.8454 | 0.7233 | 1.0136 | 0.6196 | 0.8766 | 21.78% |
| 1986 | 0.6684 | 0.4050 | 0.8521 | 0.4050 | 0.7198 | 76.72% |
| 1985 | 0.3199 | 0.2528 | 0.4120 | 0.2388 | 0.4073 | 61.12% |
| 1984 | 0.2828 | 0.4026 | 0.4073 | 0.2364 | 0.2528 | -34.95% |
| 1983 | 0.4577 | 0.5045 | 0.5548 | 0.3792 | 0.3886 | -22.61% |
| 1982 | 0.3932 | 0.3628 | 0.5244 | 0.3184 | 0.5021 | 39.71% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $107.939B | $31.227B |
| Medtronic, Inc. acquired Ireland-based Covidien plc. The acquisition resulted in the formation of a new holding company incorporated in Ireland - Medtronic plc. The company currently generates revenues from four major segments - namely Cardiovascular Portfolio, Medical Surgical Portfolio, Neuroscience Portfolio and Diabetes. The Cardiovascular Portfolio, formerly reported as the Cardiac and Vascular Group, includes the Cardiac Rhythm & Heart Failure, Structural Heart & Aortic and Coronary & Peripheral Vascular divisions. The Medical Surgical Portfolio, formerly reported as the Minimally Invasive Therapies Group, includes the Surgical Innovations and the Respiratory, Gastrointestinal & Renal divisions. Neuroscience consists of Cranial & Spinal Technologies, Specialty The Neuroscience Portfolio, formerly reported as the Restorative Therapies Group, includes the Cranial & Spinal Technologies, Specialty Therapies, and Neuromodulation divisions. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $186.688B | 24.51 |
| Stryker (SYK) | United States | $127.423B | 31.59 |
| Boston Scientific (BSX) | United States | $101.215B | 33.65 |
| EssilorLuxottica (ESLOY) | France | $99.656B | 0.00 |
| Lonza Group Ag (LZAGY) | Switzerland | $42.872B | 0.00 |
| Haleon (HLN) | United Kingdom | $38.401B | 30.04 |
| ResMed (RMD) | United States | $27.097B | 27.09 |
| Terumo (TRUMY) | Japan | $25.416B | 35.90 |
| Zimmer Biomet Holdings (ZBH) | United States | $24.968B | 16.07 |
| Baxter (BAX) | United States | $20.831B | 15.19 |
| Koninklijke Philips (PHG) | Netherlands | $19.511B | 15.56 |
| Insulet (PODD) | United States | $11.713B | 61.50 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $10.842B | 0.00 |
| Demant (WILYY) | Denmark | $9.943B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $8.136B | 24.24 |
| BellRing Brands (BRBR) | United States | $7.357B | 39.56 |
| Lantheus Holdings (LNTH) | United States | $4.415B | 11.40 |
| Haemonetics (HAE) | United States | $4.320B | 22.10 |
| Perrigo (PRGO) | Ireland | $4.132B | 11.82 |
| GN Store Nord (GNNDY) | Denmark | $3.937B | 25.50 |
| Prestige Consumer Healthcare (PBH) | United States | $3.536B | 16.72 |
| Envista Holdings (NVST) | United States | $3.475B | 13.22 |
| QuidelOrtho (QDEL) | United States | $2.702B | 9.81 |
| Neogen (NEOG) | United States | $2.666B | 25.65 |
| Green Thumb Industries (GTBIF) | United States | $2.566B | 81.33 |
| ICU Medical (ICUI) | United States | $2.382B | 17.77 |
| TG Therapeutics (TGTX) | United States | $2.202B | 712.50 |
| Owens & Minor (OMI) | United States | $1.959B | 18.80 |
| Maravai LifeSciences Holdings (MRVI) | United States | $1.941B | 0.00 |
| Agios Pharmaceuticals (AGIO) | United States | $1.788B | 0.00 |
| Verano Holdings (VRNOF) | United States | $1.662B | 0.00 |
| National Vision Holdings (EYE) | United States | $1.475B | 45.95 |
| InMode (INMD) | Israel | $1.459B | 7.55 |
| LeMaitre Vascular (LMAT) | United States | $1.442B | 47.58 |
| Warby Parker (WRBY) | United States | $1.318B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.304B | 9.81 |
| AtriCure (ATRC) | United States | $1.121B | 0.00 |
| MacroGenics (MGNX) | United States | $1.015B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.905B | 0.00 |
| BioLife Solutions (BLFS) | United States | $0.771B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.701B | 15.15 |
| Cresco Labs (CRLBF) | United States | $0.695B | 0.00 |
| Evolus (EOLS) | United States | $0.678B | 0.00 |
| Quanterix (QTRX) | United States | $0.616B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.551B | 11.94 |
| Jin Medical (ZJYL) | China | $0.543B | 0.00 |
| Valneva SE (VALN) | France | $0.539B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.492B | 0.00 |
| PetIQ (PETQ) | United States | $0.489B | 18.24 |
| ZimVie (ZIMV) | United States | $0.437B | 26.75 |
| OraSure Technologies (OSUR) | United States | $0.423B | 7.00 |
| Biote (BTMD) | United States | $0.415B | 3.95 |
| Aurora Cannabis (ACB) | Canada | $0.405B | 0.00 |
| Surmodics (SRDX) | United States | $0.383B | 41.42 |
| Zynex (ZYXI) | United States | $0.362B | 41.70 |
| Viemed Healthcare (VMD) | United States | $0.312B | 31.00 |
| Cerus (CERS) | United States | $0.305B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.281B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.273B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.242B | 14.78 |
| Organigram Holdings (OGI) | Canada | $0.201B | 0.00 |
| Ayr Wellness (AYRWF) | United States | $0.191B | 0.00 |
| Veru (VERU) | United States | $0.187B | 0.00 |
| Omeros (OMER) | United States | $0.179B | 0.00 |
| High Tide (HITI) | Canada | $0.170B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.164B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.152B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.133B | 0.00 |
| Eagleford Energy (GRUSF) | United States | $0.132B | 66.41 |
| FitLife Brands (FTLF) | United States | $0.129B | 20.70 |
| InterCure (INCR) | Israel | $0.118B | 20.00 |
| Fonar (FONR) | United States | $0.101B | 8.70 |
| Cellectar Biosciences (CLRB) | United States | $0.100B | 0.00 |
| MariMed (MRMD) | United States | $0.096B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.095B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.086B | 0.00 |
| Chimerix (CMRX) | United States | $0.083B | 0.00 |
| Brainsway (BWAY) | Israel | $0.082B | 0.00 |
| Safety Shot (SHOT) | United States | $0.080B | 0.00 |
| Eagle Pharmaceuticals (EGRX) | United States | $0.062B | 4.04 |
| Zevia PBC (ZVIA) | United States | $0.061B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.048B | 0.00 |
| Apyx Medical (APYX) | United States | $0.046B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.045B | 0.00 |
| ImmuCell (ICCC) | United States | $0.039B | 0.00 |
| Bright Green (BGXX) | United States | $0.038B | 0.00 |
| United-Guardian (UG) | United States | $0.037B | 14.54 |
| Modular Medical (MODD) | United States | $0.034B | 0.00 |
| Exagen (XGN) | United States | $0.024B | 0.00 |
| Nephros (NEPH) | United States | $0.023B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.020B | 0.00 |
| Agape ATP (ATPC) | $0.019B | 0.00 | |
| Flora Growth (FLGC) | United States | $0.019B | 0.00 |
| FSD PHARMA (HUGE) | Canada | $0.018B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.017B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.014B | 0.00 |
| GUARDION HEALTH (GHSI) | United States | $0.011B | 75.27 |
| NeuroMetrix (NURO) | United States | $0.009B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.008B | 0.00 |
| Leafly Holdings (LFLY) | United States | $0.005B | 0.00 |
| Sharps Technology (STSS) | United States | $0.005B | 0.00 |
| Senestech (SNES) | United States | $0.004B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.003B | 0.00 |
| Lucy Scientific Discovery (LSDI) | Canada | $0.002B | 0.00 |
| Akanda (AKAN) | United Kingdom | $0.001B | 0.00 |
| Smart For Life (SMFL) | United States | $0.001B | 0.00 |
| Bruush Oral Care (BRSH) | $0.000B | 0.00 | |
| SNDL (SNDL) | Canada | $0.000B | 0.00 |